159 related articles for article (PubMed ID: 9408700)
1. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Contraception; 1998 Feb; 57(2):71-81. PubMed ID: 9589832
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
4. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
[TBL] [Abstract][Full Text] [Related]
5. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
6. Once-a-month injectable contraceptives.
d'Arcangues C
World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
[TBL] [Abstract][Full Text] [Related]
8. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
[TBL] [Abstract][Full Text] [Related]
9. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
[TBL] [Abstract][Full Text] [Related]
10. Study of the effects of the implantable contraceptive Norplant on lipid and lipoprotein metabolism. UN Development Programme/UN Population Fund/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Contraception; 1999 Jan; 59(1):31-45. PubMed ID: 10342084
[TBL] [Abstract][Full Text] [Related]
11. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Koetsawang S
Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
[TBL] [Abstract][Full Text] [Related]
12. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
[TBL] [Abstract][Full Text] [Related]
13. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Hassan EO; el-Nahal N; el-Hussinie M
Contraception; 1999 Aug; 60(2):87-92. PubMed ID: 10592855
[TBL] [Abstract][Full Text] [Related]
14. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
[TBL] [Abstract][Full Text] [Related]
15. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Hassan EO; el-Nahal N; el-Hussein M
Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
Cromie MA; Maile MH; Wajszczuk CP
Contraception; 2000 Jan; 61(1):51-9. PubMed ID: 10745070
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
[TBL] [Abstract][Full Text] [Related]
18. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
el Nahal N; Hassan EO; el Houssinie M
Contraception; 1999 Jun; 59(6):369-75. PubMed ID: 10518231
[TBL] [Abstract][Full Text] [Related]
20. Existing once-a-month combined injectable contraceptives.
Toppozada MK
Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
